News
Feasibility Trial Reports Deployment of New Device for TAVI in Aortic Insufficiency
May 24, 2013 11:09 am | by European Society of Cardiology | CommentsA new investigational device—the Helio System (TF-FA) —being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of its use in high-risk aortic insufficiency reported at EuroPCR 2013.
Registry Confirms TAVI Efficacy and Safety in Asian Patients
May 24, 2013 11:05 am | by European Society of Cardiology | CommentsTranscatheter aortic valve implantation is effective and safe in Asian patients, according to early experience based on first results from a multicentre Asian registry reported at EuroPCR 2013. "TAVI has become a treatment option for selected patients with symptomatic severe aortic stenosis. But current data are virtually all from North American or European centres," Paul Chiam told the conference.
Nephosity’s MobileCT Viewer Receives FDA 510(k) Clearance for Diagnostic Image Viewing on iPads
May 24, 2013 10:55 am | by Nephosity | CommentsNephosity, a digital health startup that was a member of Rock Health’s second class, has received clearance from the United States Food and Drug Administration (FDA) for their MobileCT Viewer, a software application for diagnostic image viewing on the iPad.
Cradle Turns Smartphone into Handheld Biosensor
May 24, 2013 10:23 am | by Liz Ahlberg, Physical Sciences Editor, University of Illinois | CommentsResearchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones. University of Illinois at Urbana-Champaign researchers have developed a cradle and app for the iPhone that uses the phone’s built-in camera and processing power as a biosensor to detect toxins, proteins, bacteria, viruses, and other molecules.
Algea Therapies Launches SHIELD VCF System
May 23, 2013 5:12 pm | by The Associated Press | CommentsAUDUBON, Pa.--(BUSINESS WIRE)--May 23, 2013--Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD™ Vertebral Compression Fracture (VCF)...
Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises
May 23, 2013 4:18 pm | by PR Newswire | CommentsWASHINGTON, May 23, 2013 /PRNewswire/ -- Hearing health affects a man's lifestyle, and if he wants to stay active, feel younger, and remain socially and professionally engaged, he should address any hearing loss he may be experiencing. This is the overriding message that the...
Hansen Medical to Exhibit Magellan Robotic System at 2013 Vascular Annual Meeting of the Society for Vascular Surgery
May 23, 2013 4:03 pm | by The Associated Press | CommentsHansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will exhibit its Magellan Robotic System at the 2013 Vascular Annual Meeting® of the Society for Vascular Surgery from May 30 - June 1 at the Moscone West Convention Center in San...
First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
May 23, 2013 10:28 am | by PR Newswire | CommentsHologic, Inc. has announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's 3D mammography technology with conventional 2D mammography alone showed a significant reduction in recall rates and a sizeable increase in cancer detection, particularly invasive cancer, across all breast tissue densities.
TOPS Comprehensive Breast Center Study Validates the Benefits of New 3D Mammography Technology in Breast Cancer Screening
May 23, 2013 10:24 am | by The Associated Press | CommentsHOUSTON--(BUSINESS WIRE)--May 23, 2013--The first large-scale U.S. study comparing conventional 2D mammography screening exams alone versus 2D mammography with the addition of 3D mammography (breast tomosynthesis) technology has been completed at TOPS Comprehensive Breast Center. The study showed...
Frequent Heartburn May Predict Cancers of the Throat and Vocal Cord
May 23, 2013 10:00 am | by AACR | CommentsFrequent heartburn was positively associated with cancers of the throat and vocal cord among nonsmokers and nondrinkers, and the use of antacids, but not prescription medications, had a protective effect, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Cardiovascular Systems Presents New Late-Breaking Coronary Results at EuroPCR Conference
May 23, 2013 10:00 am | by The Associated Press | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--May 23, 2013--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), presented 30-day results from its ORBIT II study of coronary artery disease in a late-breaking presentation at the 2013 European Association of Percutaneous Cardiovascular Interventions (EuroPCR)...
Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results
May 23, 2013 9:29 am | by PR Newswire | CommentsTARRYTOWN, N.Y., May 23, 2013 /PRNewswire/ -- Direct to implant, or "one step," breast reconstruction following mastectomy is an appropriate option for many women with BRCA (BReast CAncer) gene mutations seeking to surgically reduce their breast cancer risk, or with breast...
Study Finds 35 to 42 Percent Daily Cost Savings for Hospitals Using Flexi-Seal® Fecal Management System
May 23, 2013 9:00 am | by PR Newswire | CommentsSKILLMAN, N.J., May 23, 2013 /PRNewswire/ -- A new study of the costs of managing fecal incontinence in intensive care units (ICUs) at two Canadian hospitals has found a 35 to 42 percent decrease in daily material costs with the Flexi-Seal® Fecal Management System (FMS) compared...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO Annual Meeting
May 23, 2013 8:30 am | by The Associated Press | CommentsAtossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company, will display its ForeCYTE Breast Health Test at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, from May 31 through June 4, 2013. Atossa's exhibit will be located in booth 2019...
Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference
May 23, 2013 8:30 am | by PR Newswire | CommentsTEL AVIV, Israel, May 23, 2013 /PRNewswire/ -- Israel Brain Technologies (IBT) has announced the launch of BrainTech Israel 2013, Israel's 1st International Brain Technology Conference, which will take place on October 14th-15th in Tel Aviv, recently ranked as the 2nd most innovative...
